BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10897610)

  • 1. [Metabolic disorders in children with urolithiasis].
    Finke D; Tkaczyk M; Jander A; Sałacińska B; Jasińska-Okonek A
    Pol Merkur Lekarski; 2000 Apr; 8(46):198-9. PubMed ID: 10897610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sodium excretion in children with lithogenic disorders].
    Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O
    Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoters and inhibitors of calcium urolithiasis in children.
    Lama G; Carbone MG; Marrone N; Russo P; Spagnuolo G
    Child Nephrol Urol; 1990; 10(2):81-4. PubMed ID: 2253256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metabolic etiology of urinary calculi in children].
    Gołabek B
    Probl Med Wieku Rozwoj; 1982; 11():65-81. PubMed ID: 7178091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic factors associated with urinary calculi in children.
    Naseri M; Varasteh AR; Alamdaran SA
    Iran J Kidney Dis; 2010 Jan; 4(1):32-8. PubMed ID: 20081302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical evaluation and treatment of urolithiasis.
    Nicoletta JA; Lande MB
    Pediatr Clin North Am; 2006 Jun; 53(3):479-91, vii. PubMed ID: 16716792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary metabolic evaluations in normal and stone forming children.
    DeFoor W; Asplin J; Jackson E; Jackson C; Reddy P; Sheldon C; Erhard M; Minevich E
    J Urol; 2006 Oct; 176(4 Pt 2):1793-6. PubMed ID: 16945651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The evaluation of patients with urinary calculi discloses disturbances of metabolism in 75% of all cases (author's transl)].
    Rummelhardt S; Zechner O
    Wien Klin Wochenschr; 1979 Aug; 91(15):503-9. PubMed ID: 473769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cause of hematuria in children with special consideration of urolithiasis. Personal observations].
    Wierzchowska E; Czyzowska J; Stepniewski S
    Przegl Lek; 1997; 54(7-8):554-7. PubMed ID: 9480469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of calcium, oxalate, and citrate interaction in idiopathic calcium urolithiasis in children.
    Milosević D; Batinić D; Konjevoda P; Blau N; Stambuk N; Nizić L; Vrljicak K; Batinić D
    J Chem Inf Comput Sci; 2003; 43(6):1844-7. PubMed ID: 14632431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Conservative treatment of urolithiasis in children].
    Gadomska-Prokop K; Konopielko Z
    Pol Merkur Lekarski; 2000 Apr; 8(46):190-3. PubMed ID: 10897607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uric acid: an abettor or protector in calcium oxalate urolithiasis? Biochemical study in stone formers.
    Srinivasan S; Kalaiselvi P; Sakthivel R; Pragasam V; Muthu V; Varalakshmi P
    Clin Chim Acta; 2005 Mar; 353(1-2):45-51. PubMed ID: 15698589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uric acid excretion in children with urolithiasis.
    Miller LA; Noe HN; Stapleton FB
    J Pediatr; 1989 Dec; 115(6):923-6. PubMed ID: 2585228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors.
    Caudarella R; Vescini F; Buffa A; Sinicropi G; Rizzoli E; La Manna G; Stefoni S
    J Nephrol; 2003; 16(2):260-6. PubMed ID: 12768074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
    BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
    Sakhaee K; Poindexter JR; Griffith CS; Pak CY
    J Urol; 2004 Sep; 172(3):958-61. PubMed ID: 15311008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.